Stephen Patrick Bergin, MD

Medical Instructor in the Department of Medicine
Campus mail Hanes House 105, DUMC 102355, Durham, NC 27710
Phone (919) 681-5231

Education and Training

  • Pulmonary and Critical Care Medicine Fellowship, Medicine, Duke University School of Medicine, 2014 - 2017
  • Chief Resident, Internal Medicine, Medicine, Duke University School of Medicine, 2013 - 2014
  • Internal Medicine Residency, Medicine, Duke University School of Medicine, 2009 - 2012
  • M.D., University of Mississippi School of Medicine, 2009
  • M.D., University of Mississippi, 2009

Publications

Bergin, SP, and Tsalik, EL. "Procalcitonin: The Right Answer but to Which Question?." Clinical Infectious Diseases 65, no. 2 (July 15, 2017): 191-193.

Full Text

Bergin, SP, Coles, A, Farley, J, Santiago, J, Calvert, S, Fowler, VG, and Holland, TL. "Predicting Pneumonia: A Prospective Observational Study Of The Risk Factors For Hospital-Acquired And Ventilator-Associated Bacterial Pneumonia." 2017.

Scholars@Duke

Bergin, SP, and Rackley, CR. "Managing Respiratory Failure in Obstructive Lung Disease." Clinics in chest medicine 37, no. 4 (December 2016): 659-667. (Review)

PMID
27842746
Full Text

Bergin, SP, Holland, TL, Fowler, VG, and Tong, SYC. "Bacteremia, Sepsis, and Infective Endocarditis Associated with Staphylococcus aureus." Current topics in microbiology and immunology (December 8, 2015).

PMID
26659121
Scholars@Duke

Thaden, JT, Ericson, JE, Cross, H, Bergin, SP, Messina, JA, Fowler, VG, Benjamin, DK, Clark, RH, Hornik, CP, Smith, PB, and Antibacterial Resistance Leadership Group, . "Survival Benefit of Empirical Therapy for Staphylococcus aureus Bloodstream Infections in Infants." The Pediatric infectious disease journal 34, no. 11 (November 2015): 1175-1179.

PMID
26222060
Full Text

Bergin, SP, Thaden, JT, Ericson, JE, Cross, H, Messina, J, Clark, RH, Fowler, VG, Benjamin, DK, Hornik, CP, Smith, PB, and Antibacterial Resistance Leadership Group, . "Neonatal Escherichia coli Bloodstream Infections: Clinical Outcomes and Impact of Initial Antibiotic Therapy." The Pediatric infectious disease journal 34, no. 9 (September 2015): 933-936.

PMID
26065862
Full Text

Alvarez-Breckenridge, CA, Yu, J, Price, R, Wei, M, Wang, Y, Nowicki, MO, Ha, YP, Bergin, S, Hwang, C, Fernandez, SA, Kaur, B, Caligiuri, MA, and Chiocca, EA. "The histone deacetylase inhibitor valproic acid lessens NK cell action against oncolytic virus-infected glioblastoma cells by inhibition of STAT5/T-BET signaling and generation of gamma interferon." Journal of virology 86, no. 8 (April 2012): 4566-4577.

PMID
22318143
Full Text